Home
>
National Drug Code (NDC)
>
LETROZOLE
LETROZOLE - 57884-2021-1 - (LETROZOLE)
Drug Information of LETROZOLE
| Product NDC: | 57884-2021 |
| Proprietary Name: | LETROZOLE |
| Non Proprietary Name: | LETROZOLE |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; LETROZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LETROZOLE
| Product NDC: | 57884-2021 |
| Labeler Name: | Jiangsu Hengrui Pharmaceutical Co., Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202716 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130516 |
Package Information of LETROZOLE
| Package NDC: | 57884-2021-1 |
| Package Description: | 30 TABLET in 1 BOTTLE (57884-2021-1) |
NDC Information of LETROZOLE
| NDC Code | 57884-2021-1 |
| Proprietary Name | LETROZOLE |
| Package Description | 30 TABLET in 1 BOTTLE (57884-2021-1) |
| Product NDC | 57884-2021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LETROZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130516 |
| Marketing Category Name | ANDA |
| Labeler Name | Jiangsu Hengrui Pharmaceutical Co., Ltd. |
| Substance Name | LETROZOLE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
